FibroGen (FGEN) Tops Q2 EPS by 10c

FibroGen (NASDAQ: FGEN) reported Q2 EPS of $0.83, $0.10 better than the analyst estimate of $0.73. Revenue for the quarter came in at $120.55 million versus the consensus estimate of $111.75 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM